A portfolio of medical software products that cover the entirety of behavioural treatment needs of cancer patients.
Project is a medical company creating digital therapeutic products for cancer patients. They own a portfolio of medical software products that cover the entirety of behavioral treatment needs of cancer patients. The clinically validated digital therapeutics platform will be prescribed by doctors and therapists in Germany, and it will be reimbursed by the local healthcare system from Q1 2022. The company aims to become #1 global digital therapeutics solution for oncology.
The existing problem is that healthcare systems around the world consistently fail to deliver sufficient behavioral and psychological support for cancer patients. Behavioral support is incredibly labor intensive and there is a significant shortage of required skilled personnel (e.g. psycho-oncologists) who are available to help.
Cancer patients that lack behavioral and psychological support are:
Company Digital Platform covers all of the patient’s behavioral needs and is an essential element of the personalized cancer patient journey. The medical self-care mobile applications designed to deliver personalized therapeutic methods for each patient, based on diagnostics and outcomes.
Digital therapeutics for oncology is a multi-billion growing opportunity, it was valued at 2,0 bn USD in 2019 and is expected to grow to 13,8 bn USD by 2027 (CAGR 20,5%). The average reimbursement price-point based on BfArM (The Federal Institute for Drugs and Medical Devices is the medical regulatory body of Germany) accepted products averages around 1,000 EUR.